Kalivir Immunotherapeutics
작성자관리자
- 등록일 26-06-10
- 조회66회
- Invested Year
- 2026
- Country
- USA
본문
KaliVir Immunotherapeutics is a clinical-stage biotechnology company that develops oncolytic virus immunotherapies for cancer treatment. Using its proprietary Vaccinia Enhanced Template (VET™) platform, the company engineers viruses that selectively target and kill cancer cells while stimulating the body's immune system to fight tumors.
관련링크
- https://kalivir.com/ (11회 연결)
